| MeSH term | MeSH ID | Detail |
|---|---|---|
| Diverticulitis | D004238 | 1 associated lipids |
| Adenocarcinoma, Follicular | D018263 | 3 associated lipids |
| Strongylida Infections | D017206 | 5 associated lipids |
| Marek Disease | D008380 | 4 associated lipids |
| Sarcoma, Avian | D001357 | 2 associated lipids |
| Facial Injuries | D005151 | 1 associated lipids |
| Granuloma, Lethal Midline | D006103 | 2 associated lipids |
| Nose Neoplasms | D009669 | 3 associated lipids |
| Pouchitis | D019449 | 3 associated lipids |
| Teratocarcinoma | D018243 | 7 associated lipids |
butyric acid
butyric acid is a lipid of Fatty Acyls (FA) class. Butyric acid is associated with abnormalities such as PARKINSON DISEASE, LATE-ONSET, Colitis, Autoimmune Diseases, Inflammatory Bowel Diseases and PARAGANGLIOMAS 2. The involved functions are known as DNA Methylation, Transcription, Genetic, chromatin modification, Gene Expression and Gene Silencing. Butyric acid often locates in Membrane, Chromatin Structure, Chromosomes, viral nucleocapsid location and Ribosomes. The associated genes with butyric acid are Locus, Genes, Dominant, Genes, rRNA, Genome and Chromatin. The related lipids are Butyrates, butyrate, Promega, Butyric Acids and Butyric Acid.
Cross Reference
Introduction
To understand associated biological information of butyric acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with butyric acid?
butyric acid is suspected in Colitis, Ulcerative Colitis, Anemia, Sickle Cell, Thalassemia, PARKINSON DISEASE, LATE-ONSET, Infection and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with butyric acid
PubChem Associated disorders and diseases
What pathways are associated with butyric acid
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with butyric acid?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with butyric acid?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with butyric acid?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with butyric acid?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with butyric acid?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with butyric acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Early JV et al. | Oxadiazoles Have Butyrate-Specific Conditional Activity against Mycobacterium tuberculosis. | 2016 | Antimicrob. Agents Chemother. | pmid:27044545 |
| Hoberg KA et al. | Inhibitory effect of cerulenin and sodium butyrate on germination of Candida albicans. | 1983 | Antimicrob. Agents Chemother. | pmid:6357077 |
| Rocchi P et al. | Growth inhibitory and differentiating effects of sodium butyrate on human neuroblastoma cells in culture. | 1992 May-Jun | Anticancer Res. | pmid:1622149 |
| Kyritsis AP et al. | Control of retinoblastoma cell growth by differentiating agents: current work and future directions. | 1986 May-Jun | Anticancer Res. | pmid:2427007 |
| Lea MA and Randolph VM | Induction of reporter gene expression by inhibitors of histone deacetylase. | 1998 Jul-Aug | Anticancer Res. | pmid:9703934 |
| Sarkar S et al. | Histone deacetylase inhibitors reverse CpG methylation by regulating DNMT1 through ERK signaling. | 2011 | Anticancer Res. | pmid:21868513 |
| Lee IS et al. | Suppressive effects of Adenophora triphylla extracts on in vitro tumor cell growth and in vivo gastric epithelial proliferation. | 2000 Sep-Oct | Anticancer Res. | pmid:11062747 |
| Yoshida M et al. | Effect of hexafluoro-1,25-dihydroxyvitamin D3 and sodium butyrate combination on differentiation and proliferation of HL-60 leukemia cells. | 1992 Nov-Dec | Anticancer Res. | pmid:1363510 |
| Kim J et al. | Sodium butyrate regulates androgen receptor expression and cell cycle arrest in human prostate cancer cells. | Anticancer Res. | pmid:17970072 | |
| Tsai LC et al. | Apoptosis induced by the sodium butyrate in human gastric cancer TMK-1 cells. | 2000 Jul-Aug | Anticancer Res. | pmid:10953308 |
| Gabius S et al. | Regulation of distribution, amount and ligand affinity of sugar receptors in human colon carcinoma cells by treatment with sodium butyrate, retinoic acid and phorbol ester. | 1990 Jul-Aug | Anticancer Res. | pmid:2382971 |
| Decrion-Barthod AZ et al. | Sodium butyrate with UCN-01 has marked antitumour activity against cervical cancer cells. | 2010 | Anticancer Res. | pmid:21036719 |
| Durdux M et al. | Fluorescence-based assessment of LRP activity: a comparative study. | Anticancer Res. | pmid:15161018 | |
| Lea MA et al. | Inhibition of growth and induction of differentiation of colon cancer cells by peach and plum phenolic compounds. | 2008 Jul-Aug | Anticancer Res. | pmid:18751377 |
| Louache F et al. | Characterization of phorbol esters binding to K 562 cells. | 1984 Jan-Apr | Anticancer Res. | pmid:6324650 |
| Singh NP and Lai HC | Synergistic cytotoxicity of artemisinin and sodium butyrate on human cancer cells. | Anticancer Res. | pmid:16309236 | |
| Boulikas T | Poly(ADP-ribose) synthesis in blocked and damaged cells and its relation to carcinogenesis. | 1992 May-Jun | Anticancer Res. | pmid:1535771 |
| Lacroix J et al. | In vitro and in vivo activity of 1-aryl-3-(2-chloroethyl) urea derivatives as new antineoplastic agents. | 1988 Jul-Aug | Anticancer Res. | pmid:3052247 |
| Kuwajima A et al. | The histone deacetylase inhibitor butyrate inhibits melanoma cell invasion of Matrigel. | 2007 Nov-Dec | Anticancer Res. | pmid:18225587 |
| Lea MA et al. | Induction of differentiation of colon cancer cells by combined inhibition of kinases and histone deacetylase. | Anticancer Res. | pmid:17465197 | |
| Miki Y et al. | Butyrate inhibits oral cancer cell proliferation and regulates expression of secretory phospholipase A2-X and COX-2. | Anticancer Res. | pmid:17595767 | |
| Ramp U et al. | Differentiation induction in the human rhabdomyosarcoma cell line TE-671. A morphological, biochemical and molecular analysis. | 1995 Jan-Feb | Anticancer Res. | pmid:7733631 |
| Pellizzaro C et al. | Cholesteryl butyrate in solid lipid nanospheres as an alternative approach for butyric acid delivery. | 1999 Sep-Oct | Anticancer Res. | pmid:10628332 |
| Wei ZL et al. | Enhancement of sodium butyrate-induced cell death by hyperthermia in HCT 116 human colorectal cancer cells. | Anticancer Res. | pmid:18630528 | |
| Katzenmaier EM et al. | Impact of sodium butyrate on the network of adhesion/growth-regulatory galectins in human colon cancer in vitro. | 2014 | Anticancer Res. | pmid:25275038 |
| Wang XM et al. | Inhibition of proliferation, invasion and adhesion of liver cancer cells by 5-azacytidine and butyrate. | 1999 Jul-Aug | Anticancer Res. | pmid:10652571 |
| Gladhaug IP et al. | Regulation of hepatocyte epidermal growth factor receptors by n-butyrate and dimethyl sulfoxide: sensitivity to modulation by the tumor promoter TPA. | 1989 Nov-Dec | Anticancer Res. | pmid:2627113 |
| Lea MA et al. | Addition of 2-deoxyglucose enhances growth inhibition but reverses acidification in colon cancer cells treated with phenformin. | 2011 | Anticancer Res. | pmid:21378320 |
| Litvak DA et al. | Induction of apoptosis in human gastric cancer by sodium butyrate. | 2000 Mar-Apr | Anticancer Res. | pmid:10810354 |
| Lea MA et al. | Inhibition of growth and induction of differentiation markers by polyphenolic molecules and histone deacetylase inhibitors in colon cancer cells. | 2010 | Anticancer Res. | pmid:20332434 |
| Yamamura T et al. | Sodium butyrate, a histone deacetylase inhibitor, regulates Lymphangiogenic factors in oral cancer cell line HSC-3. | 2014 | Anticancer Res. | pmid:24692699 |
| Petit JM et al. | mdr 1 gene-expression and villin synthesis in a colon cancer cell line differentiated by sodium butyrate. | 1993 Mar-Apr | Anticancer Res. | pmid:8517666 |
| Lea MA et al. | Butyramide and monobutyrin: growth inhibitory and differentiating agents. | 1993 Jan-Feb | Anticancer Res. | pmid:8476205 |
| Kato K | Endometrial cancer stem cells: a new target for cancer therapy. | 2012 | Anticancer Res. | pmid:22641664 |
| Sjöholm A | Sodium butyrate inhibits rat insulinoma cell proliferation without affecting the cellular insulin content or insulin release. | 1993 | Anticancer Drugs | pmid:8490204 |
| Fagot D et al. | Antiproliferative effects of sodium butyrate in adriamycin-sensitive and -resistant human cancer cell lines. | 1994 | Anticancer Drugs | pmid:7858287 |
| Massart C et al. | Effect of all-trans retinoic acid and sodium butyrate in vitro and in vivo on thyroid carcinoma xenografts. | 2006 | Anticancer Drugs | pmid:16702813 |
| Serpe L et al. | Cholesteryl butyrate solid lipid nanoparticles as a butyric acid pro-drug: effects on cell proliferation, cell-cycle distribution and c-myc expression in human leukemic cells. | 2004 | Anticancer Drugs | pmid:15166628 |
| Dong QG et al. | Isolation of a mitomycin-resistant human lung adenocarcinoma cell subline to investigate the modulation by sodium butyrate of cell growth and drug resistance. | 1993 | Anticancer Drugs | pmid:8298162 |
| Gonçalves P et al. | The effect of clotrimazole on energy substrate uptake and carcinogenesis in intestinal epithelial cells. | 2012 | Anticancer Drugs | pmid:22075978 |
| Massart C et al. | Effect of sodium butyrate on doxorubicin resistance and expression of multidrug resistance genes in thyroid carcinoma cells. | 2005 | Anticancer Drugs | pmid:15711177 |
| Tolstykh IV et al. | [Extraction of rifamycin B from native and aqueous solutions]. | 1975 | Antibiotiki | pmid:237467 |
| Vatin AE and Filatov PP | [Pharmacokinetics of C14-olivomycin in the body of mice with lymphosarcoma (L10-1 strain)]. | 1975 | Antibiotiki | pmid:1173211 |
| Tukey RH and Strassburg CP | Human UDP-glucuronosyltransferases: metabolism, expression, and disease. | 2000 | Annu. Rev. Pharmacol. Toxicol. | pmid:10836148 |
| Sanderson IR and Naik S | Dietary regulation of intestinal gene expression. | 2000 | Annu. Rev. Nutr. | pmid:10940337 |
| Haraguchi N et al. | CD133+CD44+ population efficiently enriches colon cancer initiating cells. | 2008 | Ann. Surg. Oncol. | pmid:18663533 |
| Wang XM et al. | Effects of 5-azacytidine and butyrate on differentiation and apoptosis of hepatic cancer cell lines. | 1998 | Ann. Surg. | pmid:9637556 |
| Nguyen KA et al. | Dietary fiber enhances a tumor suppressor signaling pathway in the gut. | 2006 | Ann. Surg. | pmid:16632996 |
| Bode BP and Souba WW | Modulation of cellular proliferation alters glutamine transport and metabolism in human hepatoma cells. | 1994 | Ann. Surg. | pmid:7944654 |
| Khan MZ et al. | Induction of phenotypic changes in SCLC cell lines in vitro by hexamethylene bisacetamide, sodium butyrate, and cyclic AMP. | 1993 | Ann. Oncol. | pmid:8394737 |